Adenine derivative as inhibitors of HSP90 for the treatment of cancer
US8217050B2 · kind B2 · utility
12Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 5, 2007 |
| Grant date | Jul 10, 2012 |
| Priority date | — |
| Expiry date | Nov 16, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a compound which is (a) an amino acid derivative of formula (I) or a tautomer thereof, or (b) a pharmaceutically acceptable salt, N-oxide, hydrate or solvate thereof: wherein R1, R2, L1, Het, A, x, y and W are as defined herein. The compounds are useful in the treatment of diseases mediated by HSP90.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.